Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 610-916-8 | CAS number: 5294-61-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 November 2011 - 19 November 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test method according to OECD Guideline 438. GLP study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.48 (Isolated chicken eye test method for identifying occular corrosives and severe irritants)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide
- EC Number:
- 610-916-8
- Cas Number:
- 5294-61-1
- Molecular formula:
- C14H21N3O
- IUPAC Name:
- N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide
- Details on test material:
- - Name of test material (as cited in study report): N-(2,6-dimethylphenyl)-1-piperazineacetamide
- Physical state: solid
- Analytical purity: 99.8%
- Lot/batch No.: M13856C
- Expiration date of the lot/batch: December 2015
- Storage condition of test material: room temperature, i.e. 15-30ºC.
Constituent 1
Test animals / tissue source
- Species:
- other: chicken.
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Zakład Przemysłu Drobiarskiego JAS-DROP in Krzyżowice.
- Age at study initiation: 7 weeks old.
- Weight at study initiation: 1.5 - 2.5 kg
BIOLOGICAL MATERIAL
After sedation of the chickens by electric shock and incision of the neck for bleeding, their heads were transported to a laboratory in a plastic container at ambient temperature. During the transport, the heads were humidified with a physiological salt solution by placing moistened paper towels inside the container. The time interval between the collection of the chickens’ heads and the use of their eyeballs in the ICE test was 30 minutes.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.03 g. - Duration of treatment / exposure:
- 10 seconds.
- Observation period (in vivo):
- 4 hours.
- Number of animals or in vitro replicates:
- 9 eyeballs: 3 eyeballs per group (test item, positive control and negative control).
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): Yes (physiological salt)
- Time after start of exposure: 10 seconds.
MEASURED PARAMETERS: the corneas treated with the test item and the control items were evaluated pre-treatment and starting at 30, 75, 120, 180 and 240 minutes (± 5 minutes) after the post-treatment rinse. At all observation times points, corneal opacity, corneal swelling, and morphological changes of the corneal surface were recorded. Fluorescein retention was determined once, 30 minutes after the end of the exposure.
SCORING SYSTEM:
Fluorescein retention:
0 No fluorescein retention
0.5 Very minor single cell staining
1 Single cell staining scattered throughout the treated area of the cornea
2 Focal or confluent dense single cell staining
3 Confluent large areas of the cornea retaining fluorescein
Corneal opacity:
0 No opacity
0.5 Very faint opacity
1 Scattered or diffuse areas; details of the iris are clearly visible
2 Easily discernible translucent areas; details of the iris are slightly obscured
3 Severe corneal opacity; no specific details of the iris are visible; size of the pupil is barely discernible
4 Complete corneal opacity; iris invisible
Corneal swelling:
Corneal swelling was determined by measuring corneal thickness with the SP-100 pachymeter (TOMEY).
Gross examination of the treated corneas:
To determine whether any morphological effects, e.g. pitting of corneal epithelial cells, roughening of the corneal surface, and sticking of the test item to the cornea were visible.
Histopathological examinations of the treated corneas:
Following the final evaluation of the treated eyeballs (240 minutes after the application of the test item and the control items), the eyeballs were fixed in a 4% formaldehyde solution. Next, one slice from each eyeball covering the cornea with the surrounding sclera was collected. The tissue material was dehydrated and prepared using a paraffin technique. Paraffin blocks were cut into smaller parts, whose thickness were 5 μm, with a microtome and stained using Hematoxylin and Eosin. The following layers of the cornea were evaluated: anterior epithelium, anterior elastic lamina (Bowman’s membrane), corneal stroma, posterior elastic lamina (Descemet’s membrane), and posterior epithelium.
Results and discussion
In vivo
- Irritant / corrosive response data:
- On the grounds of the study results and the overall in vitro irritancy classification, it may be stated that the test item can cause eye damage. According to the UN GHS classification criteria, the test item can be classified into Category 1, since the ICE class combination of the 3 endpoints was 3xIV (the first run) and 3xIV (the second run).
Any other information on results incl. tables
Table 1a. Fluorescein retention - the first run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.0 |
IV |
3.0 |
IV |
0.0 |
I |
Table 1b. Fluorescein retention - the second run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.0 |
IV |
3.0 |
IV |
0.0 |
I |
Table 2a. Corneal opacity - the first run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
75 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
120 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
180 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
240 |
2.3 |
III |
4.0 |
IV |
0.0 |
I |
Table 2b. Corneal opacity - the second run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
75 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
120 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
180 |
2.7 |
IV |
4.0 |
IV |
0.0 |
I |
240 |
2.3 |
III |
4.0 |
IV |
0.0 |
I |
Table 3a. Corneal swelling (%) - the first run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
44.30 |
IV |
81.19 |
IV |
1.53* |
I |
75 |
28.47 |
IV |
78.24 |
IV |
2.67* |
I |
120 |
52.05 |
IV |
87.44 |
IV |
1.58* |
I |
180 |
58.52 |
IV |
88.52 |
IV |
1.84* |
I |
240 |
64.95 |
IV |
72.66 |
IV |
2.62* |
I |
“-“ = decrease in corneal thickness, no swelling.
Table 3b. Corneal swelling (%) - the second run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
34.95 |
IV |
84.91 |
IV |
0.13* |
I |
75 |
29.33 |
IV |
98.70 |
IV |
1.85* |
I |
120 |
32.37 |
IV |
96.63 |
IV |
3.85* |
I |
180 |
54.28 |
IV |
107.89 |
IV |
5.84* |
I |
240 |
50.43 |
IV |
107.15 |
IV |
7.29* |
I |
“-“ = decrease in corneal thickness, no swelling.
Table 4a. Gross examinations of the treated corneas - the first run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
||||||
Eyeball no. |
Eyeball no. |
Eyeball no. |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
30 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
75 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
120 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
180 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
240 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
NC = no changes
SIGNS = roughening of the corneal surface
Table 4b. Gross examinations of the treated corneas - the second run.
Observation after time t (minutes) |
Test item |
Positive control (imidazole) |
Negative control (physiological saline) |
||||||
Eyeball no. |
Eyeball no. |
Eyeball no. |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
30 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
75 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
120 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
180 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
240 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
NC = no changes
SIGNS = roughening of the corneal surface
Histopathological examinations of the corneas:
First run: The negative control corneas had a normal histological structure. The only exception was eyeball no. 8 in which exfoliation of the anterior corneal epithelium was stated. Histopathological examinations of the positive control corneas revealed defects of the anterior corneal epithelium (eyeballs no. 4, 5, and 6) and detachment of the anterior corneal epithelium (eyeball no. 5). These changes confirmed corrosive properties of imidazole. Histopathological examinations of the corneas treated with the test item showed dissection of the anterior corneal epithelium in all eyeballs (eyeballs no. 1, 2, and 3), defects of the anterior corneal epithelium (eyeballs no. 1 and 3), and necrosis of the anterior corneal epithelium (eyeball no. 3).
Second run: The negative control corneas had a normal histological structure. Histopathological examinations of the positive control corneas revealed defects of the anterior corneal epithelium (eyeballs no. 4, 5 and 6), detachment of the anterior corneal epithelium (eyeball no. 5), dissection of the anterior corneal epithelium (eyeballs no. 4 and 6), and cell vacuolation of the anterior corneal epithelium (eyeball no. 6). These changes confirmed corrosive properties of imidazole.
Histopathological examinations of the corneas treated with the test item showed dissection of the anterior corneal epithelium (eyeballs no. 1, 2, and 3), defects of the anterior corneal epithelium (eyeballs no. 2 and 3), and cell vacuolation of the anterior corneal epithelium (eyeball no. 2).
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- The test item can cause eye damage. According to UN GHS classification criteria, the test item can be classified into Category 1, since the ICE class combination of the 3 endpoints was 3xIV (the first run) and 3xIV (the second run).
- Executive summary:
The isolated chicken eye test (in vitro) was performed according to OECD Guideline 438 and EU Method B.48 (GLP study). Toxic effects to the cornea were measured by a qualitative assessment of damage to epithelium based on application of fluorescein to the eye (fluorescein retention), a qualitative assessment of opacity, a quantitative measurement of increased thickness (swelling), and macroscopic and histopathological examinations of morphological damage to the surface. The study was conducted in two runs. The test item (ground to a powder) and the item used in the positive control (imidazole) were applied in the amount of 0.03 g, whereas the item used in the negative control (physiological salt) was applied in a volume of 0.03 mL. Three eyeballs were used for the test item and each control item. Every time, the test item and the control items were applied to the corneal surface for 10 seconds and kept at temperature between 20 – 23º C. Then, they were rinsed from the eye with 20 mL of physiological salt at ambient temperature. The corneas treated with the test item and the control items were evaluated pre-treatment and starting at 30, 75, 120, 180, and 240 minutes (± 5 minutes) after the post-treatment rinse. At all observation time points, corneal opacity, corneal swelling, and morphological changes of the corneal surface were recorded. Fluorescein retention was determined once, i.e. 30 minutes after the end of the exposure. Following the final evaluation of the treated eyeballs, i.e. 240 minutes after the application of the test item and the control items, the eyeballs were fixed in a 4% solution of formaldehyde in order to allow histopathological examinations to be conducted. The test item caused eye damage. For the eyeballs treated with the test item, the mean fluorescein retention scores were 3.0 (ICE class IV) in both first and second runs. The mean corneal opacity scores ranged from 2.3 (ICE class III) to 3.0 (ICE class IV) in both rounds. The mean corneal swelling values ranged from 28.47 (ICE class IV) to 64.95 (ICE class IV) in the first run, and from 29.33 (ICE class IV) to 54.28 (ICE class IV) in the second run. These results can be accepted because the concurrent positive and negative control values fell within the acceptable ranges for the method. Gross examinations of the eyeballs treated with the test item revealed roughening of the corneal surface in both first and second run. Histopathological examinations of the corneas showed dissection of the anterior corneal epithelium and defects on the anterior corneal epithelium in both runs in addition to necrosis of the anterior corneal epithelium in the first run and cell vacuolation of the anterior corneal epithelium in the second run. According to the UN GHS classification criteria, the test item can be classified into Category 1, since the ICE class combination of the 3 endpoints was 3xIV (the first run) and 3xIV (the second run).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
